Injurious falls and subsequent adverse drug events among elderly - a Swedish population-based matched case-control study by Rausch, C et al.
  
 University of Groningen
Injurious falls and subsequent adverse drug events among elderly - a Swedish population-
based matched case-control study





IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2017
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Rausch, C., Laflamme, L., de Rooij, S. E., Bültmann, U., & Möller, J. (2017). Injurious falls and subsequent
adverse drug events among elderly - a Swedish population-based matched case-control study. BMC
Geriatrics, 17(1). https://doi.org/10.1186/s12877-017-0594-1
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
RESEARCH ARTICLE Open Access
Injurious falls and subsequent adverse drug
events among elderly - a Swedish
population-based matched case-control
study
C. Rausch1,2* , L. Laflamme1, S. E. de Rooij3, U. Bültmann2 and J Möller1
Abstract
Background: Fall injuries are stressful and painful and they have a range of serious consequences for older people.
While there is some clinical evidence of unintentional poisoning by medication following a severe fall injuries, population-
based studies on that association are lacking. This is investigated in the current study, in which attention is also paid to
different clinical conditions of the injured patients.
Methods: We conducted a matched case-control study of Swedish residents 60 years and older from various Swedish
population-based registers. Cases defined as adverse drug events (ADE) by unintentional poisoning leading to hospitalization
or death were extracted from the National Patient Register (NPR) and the Cause of Death Register from January 2006 to
December 2009 (n = 4418). To each case, four controls were matched by sex, age and residential area. Information on
injurious falls leading to hospitalization six months prior to the date of hospital admission or death from ADE by unintentional
poisoning, and corresponding date for the controls, was extracted from the NPR. Data on clinical conditions, such as
dispensed medications, comorbidity and previous fall injuries were also extracted from the Swedish Prescribed Drug
Register (SPDR) and NPR. Effect estimates were calculated using conditional logistic regression and presented as odds
ratios (OR) and 95% confidence intervals (CI).
Results: We found a three-fold increased risk of unintentional poisoning by medication in the six-month period after
an injurious fall (OR 3.03; 95% CI, 2.54–3.74), with the most pronounced increase 1–3 weeks immediately after (OR, 7.66;
95% CI, 4.86–12.1). In that time window, from among those hospitalized for a fall (n = 92), those who sustained an
unintentional poisoning (n = 60) tended to be in poorer health condition and receive more prescribed medications
than those who did not, although this was not statistically significant. Age stratified analyses revealed a higher risk of
poisoning among the younger (aged 60–79 years) than older elderly (80+ years).
Conclusion: Medication-related poisoning leading to hospitalization or death can be an ADE subsequent to an
episode of hospitalization for a fall-related injury. Poisoning is more likely to occur closer to the injurious event and
among the younger elderly. It cannot be ruled out that some of those falls are themselves ADE and early signs of
greater vulnerability among certain patients.
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Background
Fall injuries are a serious cause of morbidity among
older people and their occurrence increases dramatically
with age [1–3]. They are sustained for a variety of
different environmental and individual reasons, includ-
ing the health condition of older people [4–9]. Older
people’s health condition may in fact imply that they are
more likely to either sustain a fall or to be injured
because of a fall [2, 3, 10, 11].
While medication has an important function in man-
aging various types of health conditions, a range of
studies reveal that it may increase the risk of falling
among older people [8, 10, 12, 13]. This is the case for
specific medications like opioids [14], certain combina-
tions of medications and also for polypharmacy [8, 12].
The latter is preoccupying too as older people often
suffer from several conditions that need to be treated
simultaneously. However, even low numbers of medica-
tion used, below the polypharmacy threshold of five
medications, increase the risk for falls and other injuries
among older people [12, 15].
A recent clinical study revealed an association between
falls and the occurrence of adverse drug events (ADE)
[4]. Unintentional poisoning by medication among older
people is a very severe form of ADE that can be fatal
[15]. It may occur for various pathophysiological reasons
[16, 17] and can be triggered by a change in medication,
(e.g., in dosage, number, or type). Changes in medica-
tion, in turn, arise most typically when the health condi-
tion of older people either improves or worsens. An
example of the latter is a fall-related hospitalization,
which is frequent among older people [2] and has a
range of documented serious short- and long-term con-
sequences [18]. So far, however, there is no epidemio-
logical population-based evidence on the association
between injurious fall and subsequent poisoning by
medication.
This study aims to determine the association between
injurious falls and subsequent ADE by unintentional
poisoning, and also pays attention to different clinical
conditions of the fall-injured patients.
Methods
Study design
For the purpose of this study, a matched case-control
design was nested in a national cohort of 6,981,010 indi-
viduals. Individuals born before 1959, and domiciled in
Sweden at some point from 1973 onwards were identi-
fied using the Total Population Register. Information
from the Swedish national health registers was linked to
the cohort based on each individual’s unique personal
identification number. All hospitalizations and deaths
among elderly persons 60 years or older were identified
for the study period of 1 January 2006 to 31 December
2009, by using the Swedish National Patient Register
(NPR) and Swedish Cause of Death Register (CDR).
Participants
Cases were defined as having been hospitalized or died
due to ADE, coded as unintentional poisonings or toxic
effect by medication and noxious substances using the
NPR and CDR. Hospital discharge diagnoses were used
(ICD-10 codes: T36–65 as main diagnosis and X40–49
as external cause of morbidity) and for mortalities (ICD-
10 codes X40–49) the underlying cause of death was
used. Only the first event of ADE by unintentional
poisoning was considered during the study period. Cases
with a main diagnosis of poisoning, but no underlying
cause of poisoning related to medical treatment or
medication use (ICD-10 X45-X48, including alcohol in-
toxication) were not considered. A total of 4418 cases
were identified. Date of admission or death was used as
index date for the purpose of this study.
To each case, four controls were randomly selected
and matched by age (month and year), sex and residen-
tial area at the index time. Only individuals not subject
to any medication-related hospitalization or death, as
per case definition, during the study period were consid-
ered eligible as controls. In total 17,672 controls were
matched to the cases.
Exposure definition
Information on injurious falls leading to hospitalization
6 months prior to the index date was extracted from the
NPR, and identified based on the main discharge diag-
nose for unintentional falls (ICD-10 code W00-W19).
Only the most recent injurious falls, i.e. closest to the
index date, were considered, and fall injuries with a sec-
ondary diagnosis related to sequels from prior medical
care or medication used were excluded. No injurious fall
during the six-month period prior to the ADE was used
as reference group. Furthermore, information on pre-
vious injurious falls was extracted, and those with
more than one hospitalization for a fall injury during
the year prior to the index date, were categorized as
repeated fallers.
Covariates
Information on prescribed medications was extracted
from the Swedish Prescribed Drug Register (SPDR), a
computerized system of the pharmaceutical services,
which records all the dispensations of prescribed
medications at all pharmacies in Sweden through regis-
tration of the medications using the specific five-level
Anatomical Therapeutic and Chemical Classification
system (ATC) [19]. Exposure to medications was opera-
tionalized as number and type of prescribed and
dispensed medications based on the 5th digit level of the
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ATC code during the four months prior to the index
date. Number of prescribed medications was categorized
into 0; 1, 2, 3, 4, or 1–4; 5–9; and 10 or more. One
medication was considered as the reference group in the
analyses. Type of medications was categorized based on
medications acting on the central nervous system (CNS)
(including psychotropic ATC: N05, anti-epileptic N03,
psychoanaleptics N06, anti-histamine R06,, cholinester-
ase inhibitors N07A and anti-Parkinson medications
N04), and pain relieving medication (opioid N02A and
analgesics N02) was considered separately. In addition,
inappropriate drug use (IDU) was assessed based on the
Swedish National Board for Health and Welfare
published “Indicators of appropriate drug therapy in
elderly” (see Additional file 1: Appendix 1) [15].
Co-morbidity is independently associated with ADE
[20, 21] and was hence considered as a confounder by
using the Charlson Comorbidity Index (CCI) [22] and
number of prescribed medications (as defined above).
CCI was extracted from the NPR by considering the
hospital discharge diagnoses according to ICD-10 codes
for the three-year period prior to the index date. Seven-
teen different morbidities, including but not exclusive to
myocardial infarction, dementia and chronic obstructive
pulmonary disease, are considered in the CCI, and each
category is weighted from one to six, with a level higher
than five representing the most severe outcomes. CCI
was categorized into four groups; 0, 1–2, 3–4 and 5 or
more, with 0 serving as the reference group. The use of
the CCI in population-based health register studies has
been described and validated elsewhere [23, 24].
Additionally, civil status was considered as a potential
confounder since previous literature has shown the pro-
tective effect of being married [25]. Civil status was ex-
tracted from the Total Population Register at time of
index date and categorized into: married, unmarried, di-
vorced, widowed or unknown. Married served as the ref-
erence group.
Statistical analyses
Descriptive statistics were calculated to describe the
characteristics of the study population with regard to
demography and morbidity and a comparison was made
in the distribution among cases and controls by using
Pearson Chi-square tests (Table 1).
Conditional logistic regression was used to assess the
association between a recent fall injury and subsequent
ADE by unintentional poisoning by estimating odds ra-
tios (OR) with corresponding 95% confidence interval
(95% CI). Each potential confounder was assessed in its
association with the outcome and adjusted for in the
main analysis when showing a statistically significant ef-
fect (p-value <0.05). Civil status included missing data
(0.1%) that were excluded from the analysis. Analyses
were performed using fall injuries in the six-month
period prior to index date but were also analyzed in
smaller time intervals; 1–3 months and within 1–
3 months further categorized into 1–3 weeks, 4–6 weeks
and 7–12 weeks were performed and presented. No
injurious fall during the six-month period prior to the
ADE was used as the reference group. Results are pre-
sented overall and stratified by gender and age group
(60–79 years and 80+) (Table 2).
Individuals with recent fall injuries in the time window
with the highest risk for an ADE by unintentional
poisoning (i.e. 1–3 weeks) were further analyzed based
on their clinical characteristics before and after the
hospitalization for fall injury. The distribution of charac-
teristics is presented separately for the fall-injured with
(n = 60) and without (n = 32) a subsequent ADE (Table 3).
For the purpose of this, the number of medications was
assessed in the four-month period prior to the fall injury.
Any additional medications prescribed and dispensed
between the hospitalization for a fall injury and the
index date were considered as newly prescribed
medications (number, specific types of medications
and IDU) for the time window with the highest risk.
Table 1 Characteristics of the study population, stratified by
case and control status, percentage (%), n = 22,090









60–79 51.6 51.6 Matched
≥80 48.4 48.8

















1P–value of Pearson Chi-square tests for comparison of distribution between
cases and controls
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IBM SPSS Statistics 22 was used to perform the
statistical analyses.
Ethical approval
According to Swedish regulations, the Personal Data Act
(Personuppgiftslagen) § 10 [26], the ethical application
specified why the researchers did not consider informed
consent as necessary – or feasible (as in the case of a
large register-based study such as ours). The study was
approved by the Regional Ethical Review Committee in
Stockholm, Sweden (2010/865–31/2 and 2011/15–32).
Results
Table 1 shows that the majority of cases were female
(59.1%), were 60–79 years old (51.6%). In comparison to
the controls, cases were more likely to be subject to
Table 2 Odds Ratios for ADE by time since fall injury, stratified by gender and age group, n = 22,090
Fall injury prior
to ADE





Matcheda Adjustedb Maleb Femaleb 60–79 yearsb ≥80 yearsb
No c 3318 14,863 1.00 REF 1.00 REF 1.00 REF 1.00 REF 1.00 REF 1.00 REF
Yesc, 1–3 months 170 153 5.23 (4.17–6.58) 4.13 (3.23–5.28) 5.22 (3.44–7.94) 3.08 (2.21–4.28) 7.00 (4.27–11.5) 3.09 (2.32–4.12)
1–3 weeks 60 32 8.86 (5.76–13.6) 7.69 (4.87–12.1) 9.43 (3.56–25.0) 7.17 (4.27–12.0) 17.5 (6.23–49.6) 5.03 (2.99–8.46)
4–6 weeks 37 26 6.34 (3.83–10.5) 4.82 (2.80–8.31) 6.62 (2.80–15.6) 3.79 (1.85–7.79) 8.04 (2.92–22.1) 3.46 (1.80–6.65)
7–12 weeks 73 95 3.65 (2.76–4.99) 2.81 (2.01–3.93) 4.59 (2.71–7.77) 1.96 (1.26–3.08) 4.67 (2.37–9.06) 2.22 (1.50–3.28)
Noc 3318 14,863 1.00 REF 1.00 REF 1.00 REF 1.00 REF 1.00 REF 1.00 REF
Yesd, 1–6 months 257 275 4.31 (3.62–5.15) 3.54 (2.93–4.28) 4.88 (3.53–6.76) 2.34 (1.83–2.99) 7.86 (5.33–11.6) 2.40 (1.91–3.01)
aAdjusted through matching by sex, age and residential area
bAdjusted for matching variables, civil status and CCI
cIndividuals with a fall injury one day up to three month prior to index date
dIndividuals with a fall injury one day up to six month prior to index date
Table 3 Distribution of clinical characteristics among individuals hospitalized for fall injuries 1–3 weeks prior to the index date
stratified by subsequent ADE, n = 92
Clinical characteristics Category With ADE
n = 60% (95% CI)
Without ADE
n = 32% (95% CI)
p-value1
Prior to the fall injury
CCI 0 55.7 (43.1–68.3) 62.5 (45.7–79.3) 0.506
1–2 41.7 (29.2–54.2) 35.0 (18.5–51.5)
3–4 3.4 (0.0–8.0) 0.0
Number of prescribed medicationsa 0 5.0 (0.0–10.51) 9.4 (0.0–19.51) 0.367
1–4 8.3 (1.3–15.3) 18.8 (5.2–32.3)
5–9 45.0 (32.4–57.6) 34.4 (17.9–50.8)
>9 41.7 (29.2–54.2) 37.5 (20.7–54.3)
Repeated fallersb No 73.8 (64.0–86.0) 66.7 (52.7–84.8) 0.923
Yes 26.6 (15.5–37.9) 33.3 (17.9–50.8)
After the fall injuryc
Number of new medication 0 60.0 (47.6–72.4) 66.7 (50.3–83.0) 0.525
1–4 33.2 (21.3–45.1) 28.1 (12.5–43.7)
>4 6.8 (0.4–13.2) 3.1 (0.0–9.1)
IDU Yes 11.5 (5.0–21.8) 6.1 (1.6 – 19.6) 0.252
CNSd medication (any) Yes 28.3 (16.9–39.7) 15.6 (3.0–28.2) 0.173
Analgesics Yes 13.3 (4.7–21.9) 3.1 (0.0–9.1) 0.155
Opioids Yes 21.7 (11.3–32.1) 9.4 (0.0–19.5) 0.162
1P-value of Pearson Chi-square tests for comparison of proportion between fall-injured with and without subsequent ADE
aNumber of different medications four months prior to fall injury
bConsidering hospitalization for any fall injury up to one year prior to index date
cNew medications, i.e. medications the individual did not dispense in the four months prior to the fall injury. The presented medication categories are not
mutually exclusive
dAny medication acting on the central nervous system (CNS)
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co-morbidity (CCI >0: 18.1 vs. 43.8%) and had more
often prescribed medications (77.7 vs. 97.0%). Among
the cases, more than 50% had ten or more medications,
compared to only approximately 15% among the
controls. Among the controls, 22% did not have any
prescribed medications whereas the corresponding number
among cases was only 3%.
Table 2 shows the odds ratios for ADE by uninten-
tional poisoning in different time windows since injuri-
ous fall, stratified by gender and age group. After taking
confounding from civil status and comorbidity into
account, the odds of an ADE is higher among elderly
with an injurious fall during the last six months (OR,
3.54; 95% CI, 2.93–4.28) compared to those without.
The most pronounced increased risk was in the 1–3 weeks
after the fall injury (OR 7.69; 95% CI, 4.87–12.1), and
decreased over the six-month period but remained statis-
tically significant during the whole six-month period.
Older people aged 60–79 years showed the highest risk,
specifically in the 1–3 week time window. No gender
differences were seen, except when considering the
ADE within the six months after the injurious fall
(male OR, 4.88; 95% CI, 3.53–6.76; female OR, 2.34;
95% CI, 1.83–2.99).
In Table 3, the clinical characteristics of older people
with an injurious fall, with and without a subsequent
ADE in the 1–3 weeks, are presented in order to under-
line the potential differences with regard to prescribed
medications and comorbidity before and after the fall in-
jury. Type of fall injury (according to external cause of
fall injury) did not differ between the two groups and
neither did length of stay in the hospital due to the fall
injury (for those with a subsequent ADE) on average
9.4 days (SD 9.1) and for those without a subsequent
ADE 9.5 days (SD 8.5) (results not shown), indicating
similarly serious fall injuries in both groups. Although
not statistically significant, individuals with a subsequent
ADE after an injurious fall tend to have a higher comor-
bidity score (CCI >0: 44.3 vs. 35.0%), but tend to be less
likely to be repeated fallers (26.6 vs. 33.3%). Further, they
seem to be more likely to have received opioids (21.7 vs.
9.4%) and analgesics (13.3 vs. 3.1%) The most commonly
newly prescribed pharmaceutical drug groups were
opioids (N02A), other analgesics and antipyretics (N02B),
with paracetamol (n = 11) and oxycodone (n = 7) as the
most commonly newly prescribed medications.
Discussion
In this large population-based study, we found that the
risk of unintentional poisoning by medication is tripled
in the six-month period following an episode of
hospitalization for an injurious fall, with the excess risk
peeking 1–3 weeks immediately after the fall. This
echoes findings from an earlier clinical study [4].
Previous studies have also considered the role of co--
morbidity, polypharmacy and social factors, i.e. civil sta-
tus in regard to ADE [20, 25, 27] and found similar
results. While these studies used broader definitions of
ADE or focused predominantly on the clinical setting,
our population-based study focused on a more severe
ADE, defined by hospitalized and fatal unintentional poi-
soning events. In our data, the association remained
after adjustment for the patients’ clinical condition
(assessed herein by CCI) and civil status. In the peak
period, among the fallers, those who had a subsequent
poisoning tended to be in poorer health condition and
receive more prescribed medications than those who
were not, but were also less likely to have a previous
history of fall-related hospitalizations. Compared to
other studies concerned with length of hospital stay as
risk factor for ADE [28, 29], we did not find any signifi-
cant difference between length of hospital stay for the
injurious falls with and without ADE in the peak period.
The association between injurious fall and ADE differs
by age, where age-stratified analyses revealed a higher
risk among the younger (aged 60–79 years) than older
elder (80+ years).
As mentioned earlier, medication has the positive
benefit of helping to manage various types of health
conditions among older people. But in some circum-
stances they may have caused adverse effects, among
which fall and injurious falls are well documented ones
[8, 10, 12, 13] and unintentional poisoning, less so [15].
What makes severe injurious falls and subsequent unin-
tentional poisoning related to one another may have
different explanations. One being that the clinical condi-
tion of some of those who sustain severe fall injuries is
poor and that the fall itself is more or less a reflection of
their vulnerability to ADEs [4, 6]. In that case, suffering
from unintentional poisoning is an additional manifest-
ation of this vulnerability. In our study, however, we only
found an indication of such preconditions that would
differentiate poisoned and non-poisoned fallers.
An alternative explanation is that sustaining an injuri-
ous fall implies changes or adjustments in the patient’s
drug treatment (e.g., change in dosage, number, and
types of medications) and that this in itself may increase
the risk of ADE. That could explain why, in this study,
the excess risk of poisoning is so much more pro-
nounced shortly after the fall when changes in drug
treatment are more likely to occur. Clinical studies have
shown that changes in medication regiment can increase
the risk for ADE [20, 30].
Physicians might be less inclined to consider atypical
presentation of diseases or geriatric syndromes among
younger elder [6] and focus their intervention on the fall
injury itself rather than on potential external causes like
medication use or co-morbidity. This is less likely in the
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case of the older elder as there are guidelines for these
situations [20].
To our knowledge, this study is one of the few in the
area and the first population-based one assessing the
association between injurious falls and subsequent unin-
tentional poisoning; with only one previous study in a
clinical setting and with smaller sample size (n < 1000)
[4]. One major strength is the linkage of individual
information accessed from Swedish registers which
significantly increases the size of the study (nationwide),
with high coverage and quality of the assessment of
ADE, injurious falls and potential covariates [31]. Using
register data eliminates the risk of recall bias, which is
often a problem in case-control studies, though we can
only generalize our findings to fall injuries and poison-
ings resulting in hospitalization.
Information concerning medication over the counter
was not accessible for the study. Although this may lead
to important interactions being unnoticed, it applies
equally to cases or controls. It is also of note that we
used four months prior to the index date as a reference
period. This has the advantage of capturing chronic
medication use with long prescription routines (in
Sweden, medications are normally prescribed for a treat-
ment period of three months) but it may mean that we
miss medications prescribed on a needs basis. This could
be important especially among older people with an in-
jurious fall, who often are advised to take pain-relieving
medication when needed.
Identification of unintentional poisoning and toxic
effects by medication and noxious substances (regarded
herein as an ADE) was based on specific and appropriate
ICD diagnoses from the hospitalization and death
register and this approach has also been employed in
previous studies with other risk factors [29, 32]. How-
ever, we cannot rule out some degree of inaccuracy in
reporting to the registers as physicians might misdiag-
nose ADE with unspecific clinical presentations,
especially among older individuals [33–35].
As in previous studies, we adjusted for co-morbidity
and social factors, i.e. civil status [20, 25, 27]. We
assessed comorbidity using the Charlson Comorbidity
Index which has been described and validated for
register-based studies elsewhere [23, 24]. We acknow-
ledge, though, that there might be some residual
confounding so as an alternative measure of comorbid-
ity, we also adjusted for number of prescribed medica-
tions prior to the index date. Such adjustment did not
further reduce the effect. Having adjusted for CCI, we
refrained from including another proxy for frailty to
avoid over-adjustment and as medications prescribed
after the fall injury might act as mediators. However, we
cannot rule out that even minor changes in health con-
ditions, such as acute infections that are not captured in
registers, could contribute to the vulnerability of poison-
ing among fall injured.
Conclusions
This study shows epidemiological evidence that
medication-related poisoning leading to hospitalization
or death can be an adverse drug event subsequent to an
episode of hospitalization for a fall-related injury.
Poisoning is more likely to occur closer to the injurious
event and among older elder. It cannot be ruled out that
some of those falls are themselves ADE and early signs
of greater vulnerability among certain patients.
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